Modulation of the formation and release of bovine SRS-A in vitro by several anti-anaphylactic drugs.
Slow-reacting substance of anaphylaxis (SRS-A) is released immunologically from bovine lung in vitro. Various drugs known to protect calves and other animals during anaphylaxis were tested to investigate their modulation of the formation and release of SRS-A. The anti-inflammatory drugs, meclofenamate and aspirin, potentiated SRS-A release. Chlorphenesin and diethylcarbamazine citrate at high concentrations both inhibited SRS-A release. Two new anti-anaphylactic drugs, PR-D-92-EA and M&B 22,948, were particularly effective in inhibiting SRS-A release at low concentrations. The possible modes of actions of these drugs are discussed.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D001241:Aspirin / Q000494:pharmacology; D001372:Aza Compounds / Q000494:pharmacology; D001578:Benzopyrans / Q000494:pharmacology; D002417:Cattle; D002743:Chlorphenesin / Q000494:pharmacology; D004205:Cromolyn Sodium / Q000494:pharmacology; D004049:Diethylcarbamazine / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D066298:In Vitro Techniques; D008168:Lung / Q000276:immunology; D008297:Male; D008469:Meclofenamic Acid / Q000494:pharmacology; D011121:Polyphloretin Phosphate / Q000494:pharmacology; D011688:Purinones / Q000494:pharmacology; D011738:Pyrilamine / Q000494:pharmacology; D013189:SRS-A / Q000032:analysis / Q000096:biosynthesis / Q000378:metabolism*
D000893:Anti-Inflammatory Agents; D001372:Aza Compounds; D001578:Benzopyrans; D011688:Purinones; D013189:SRS-A; D008469:Meclofenamic Acid; C010685:PR-D-92; D011121:Polyphloretin Phosphate; D011738:Pyrilamine; D002743:Chlorphenesin; D004205:Cromolyn Sodium; D001241:Aspirin; D004049:Diethylcarbamazine